Search

everythinglearnresearchcommunity

for

Search:↓

Finasteride boosts morphine's pain relief and prevents tolerance and withdrawal in rats.

Liarozole may be more effective than cyproterone acetate for treating advanced prostate cancer, with better PSA response and survival rates, while maintaining quality of life.

Ritlecitinib effectively treats alopecia areata and is safe for long-term use in people 12 and older.

Finasteride reduces opioid use and withdrawal symptoms in animals.

Blocking GABA(A) receptors increases neuron sensitivity, showing GABA and glycine have different roles in pain.

New androgen receptor modulators show promise for treating diseases like prostate cancer and muscle wasting.

New hybrid compound found to effectively prevent hair loss.

Steroidogenesis inhibitors change but don't stop androgen production in prostate cancer.

Finasteride reduces pain in male rats and works better with testosterone.

Ritlecitinib can help about 14,000 people with severe hair loss.

RF-mesotherapy with bicalutamide may be a promising new treatment for hair loss.

LGD1069 effectively prevents breast tumors in mice without toxicity.

Some cannabinoid derivatives may be more effective than current drugs at targeting proteins relevant to prostate cancer treatment.

Analog 23 is a promising compound for prostate cancer treatment.

Blocking DHT production more strongly may help control advanced prostate cancer and improve quality of life.

Finasteride boosts morphine's pain relief, stops tolerance, and reduces withdrawal in rats.

5-Alpha-Reductase inhibitors might help slow down hair loss in Frontal Fibrosing Alopecia but are not a primary treatment and need more research.

Cepharanthine may help treat Equid herpesvirus type 8 by reducing oxidative stress.

New compounds show promise as nonsteroidal treatments for hair loss.

The oral contraceptive alone is the preferred treatment for hirsutism, as adding the GnRH analog showed no significant benefit.

Ritlecitinib shows promise for treating alopecia areata, especially with early and extended treatment.

Blocking certain proteins can reduce skin inflammation caused by cancer treatment.

5αR inhibitors help slow early prostate cancer cell growth, suggesting combined treatments are needed.

JAK inhibitors, like ruxolitinib, may effectively treat frontal fibrosing alopecia.

RNA aptamers can specifically block FGF5-related cell growth, potentially treating related diseases or hair disorders.

Compounds 4, 4b, and 4c effectively inhibit an enzyme linked to testosterone conversion without significant toxicity.

AH-001 could be a safer and more effective treatment for hair loss.

C-reactive protein helps monocytes stick to blood vessel cells by causing oxidative stress.